Synergistic antitumor activity of resveratrol and miR-200c in human lung cancer

Oncology Reports

Volumn 31, Issue 5, 2014, Pages 2293-2297

  Bai, Tao ^a   Dong, Dao Song ^a   Pei, Ling ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Lung cancer; MiR 200c; RECK; Resveratrol

Indexed keywords

MEMBRANE PROTEIN; MICRORNA 200C; RESVERATROL; REVERSION INDUCING CYSTEINE RICH PROTEIN WITH KAZAL MOTIF; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MICRORNA; MIRN200 MICRORNA, HUMAN; RECK PROTEIN, HUMAN; RIBONUCLEOTIDE REDUCTASE; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL GROWTH; CELL LINE; CELL STRAIN H460; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOLOGY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; HISTOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CANCER TRANSPLANTATION; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; LUNG NEOPLASMS; MORTALITY; NUDE MOUSE; TUMOR CELL LINE; XENOGRAFT;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION REGULATION, NEOPLASTIC; GPI-LINKED PROTEINS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; MICRORNAS; NEOPLASM TRANSPLANTATION; RIBONUCLEOTIDE REDUCTASES; STILBENES; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84898639816     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3090     Document Type: Article

References (24)

1. Ryan BM, Robles AI and Harris CC: Genetic variation in microRNA networks: The implications for cancer research. Nat Rev Cancer 10: 389-402, 2010
2. Kasinski AL and Slack FJ: MicroRNAs en route to the clinic: Progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 11: 849-864, 2011
3. Edwards JK, Pasqualini R, Arap W and Calin GA: MicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseases. J Cardiovasc Transl Res 3: 271-279, 2010
4. Tryndyak VP, Beland FA and Pogribny IP: E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Int J Cancer 126: 2575-2583, 2009
5. Korpal M, Lee ES, Hu G and Kang Y: The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283: 14910-14914, 2008
6. Park SM, Gaur AB, Lengyel E and Peter ME: The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22: 894-907, 2008
7. Hurteau GJ, Carlson JA, Roos E and Brock GJ: Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression. Cell Cycle 8: 2064-2069, 2009
8. Hugo H, Ackland ML, Blick T, et al: Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 213: 374-383, 2007
9. Lee TK, Poon RT, Yuen AP, et al: Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 12: 5369-5376, 2006
10. Miki H, Uehara N, Kimura A, et al: Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells. Int J Oncol 40: 1020-1028, 2012
11. Sheths S, Jajoo S, Kaur T, et al: Resveratrolreducesprostate cancer growth and metastasis by inhibiting the Akt/microRNA-21 pathway. PLoS One 7: E51655, 2012
12. Yin HT, Tian QZ, Guan L, Zhou Y, Huang XE and Zhang H: In vitro and in vivo evaluation of the antitumor efficiency of resveratrol against lung cancer. Asian Pac J Cancer Prev 14: 1703-1706, 2013
13. Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20, 2005
14. Jan CH, Friedman RC, Ruby JG and Bartel DP: Formation, regulation and evolution of Caenorhabditis elegans 3'UTRs. Nature 469: 97-101, 2011
15. Tang H, Deng M, Tang Y, et al: MiR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. Clin Cancer Res 19: 5602-5612, 2013
16. Ceppi P, Mudduluru G, Kumarswamy R, et al: Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol Cancer Res 8: 1207-1216, 2010
17. Furumoto K, Arii S, Mori A, et al: RECK gene expression in hepatocellular carcinoma: Correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing-cysteine-rich protein with Kazal motifs. Hepatology 33: 189-195, 2001
18. Span PN, Sweep CG, Manders P, et al: Matrix metalloprote?nase inhibitor reversion-inducing cysteine-rich protein with Kazal motif a prognostic marker for good clinical outcome in human breast carcinoma. Cancer 97: 2710-7215, 2003
19. Masui T, Doi R, Koshiba T, et al: RECK expression in pancreatic cancer: Its correlation with lower invasiveness and better prognosis. Clin Can Res 9: 1779-1784, 2003
20. Takeuchi T, Hisanaga M, Nagao M, et al: The membrane-anchored matrix metalloprote?́nase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer. Clin Cancer Res 10: 5572-5579, 2004
21. Lei L, Huang Y and Gong W: Inhibition of miR-92b suppresses nonsmall cell lung cancer cells growth and motility by targeting RECK. Mol Cell Biochem 387: 171-176, 2013
22. Chen Y, Tsai YH and Tseng SH: RECK regulated endoplasmic reticulum stress response and enhanced cisplatin-induced cell death in neuroblastoma cells. Surgery 154: 968-979, 2013
23. Moenner M, Pluquet O, Bouchecareilh M, et al: Integrated endoplasmic reticulum stress responses in cancer. Cancer Res 67: 10631-10634, 2007
24. Tamaki N, Hatano E, Taura K, et al: CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury. Am J Physiol Gastrointest Liver Physiol 294: G498-G505, 2008